Psychoeducation versus cognitive-behavioral therapy in bipolar disorder

ISRCTN ISRCTN36852818
DOI https://doi.org/10.1186/ISRCTN36852818
Secondary identifying numbers MCT-55404
Submission date
26/09/2005
Registration date
26/09/2005
Last edited
18/04/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Sagar V. Parikh
Scientific

Toronto Western Hospital
Toronto
M5T 2S8
Canada

Phone +1 416-603-5734
Email sagar_parikh@camh.net

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific title
Study objectivesTo compare the impact of cognitive-behavioral therapy to that of properly structured psycho education on the ‘illness burden’ and functional outcome of bipolar disorder, in combination with pharmacotherapy
Ethics approval(s)Centre for Addiction and Mental Health Research Ethics Board, Toronto, ON, July 9, 2001
Health condition(s) or problem(s) studiedBipolar Disorder
InterventionControl group: 6 sessions of group psycho-education (topics include illness recognition, treatment approaches, and monitoring and coping strategies; based on manual by Bauer & McBride, 2002: Life Goals Phase I)
Experimental group: 20 sessions of individual Cognitive Behavioural Therapy for Bipolar Disorder (topics include limited psychoeducation, activity scheduling/behavioural interventions, cognitive techniques, including thought monitoring and challenges to dysfunctional assumptions and other coping techniques; based on manual by Lam et al., 1999: Cognitive Therapy for Bipolar Disorder

Trial details received: 12 Sept 2005
Intervention typeOther
Primary outcome measureMania and depression
Secondary outcome measures1. Health care utilization
2. Social and occupational functioning scales
3. Quality of life
Overall study start date01/04/2002
Completion date31/03/2005

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants210
Key inclusion criteria1. Bipolar I and II
2. Currently either in remission or subsyndromally ill (Ham-D-29 <14; CARS-M <12)
3. Age ≥18, either sex
4. Significant symptoms and/or episodes on at least 2 occasions in the past 3 years
5. Grade 6 education able to understand English, and Folstein Minimental Score Exam >26 to ensure cognitive ability to participate
6. On mood-stabilizing medication.
Key exclusion criteria1. Substance dependence meeting DSM-IV criteria within the last 3 months
2. Acutely high suicidal or homicidal
3. Serious other medical conditions that would render pharmacotherapy or psychotherapy very difficult i.e. cancer, severe diabetes etc.
4. Severe antisocial or borderline personality disorder
Date of first enrolment01/04/2002
Date of final enrolment31/03/2005

Locations

Countries of recruitment

  • Canada

Study participating centre

Toronto Western Hospital
Toronto
M5T 2S8
Canada

Sponsor information

University of Toronto (Canada)
Not defined

27 King's College Circle
Toronto
M5S 1A1
Canada

ROR logo "ROR" https://ror.org/03dbr7087

Funders

Funder type

Research organisation

Canadian Institutes of Health Research (CIHR) (Canada) - http://www.cihr-irsc.gc.ca (ref: MCT-55404)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan